Trial intelligence / Profile preview

Low-dose hyperbaric bupivacaine plus fascia iliaca compartment block in elderly hip fracture surgery at Phrae Hospital

TCTR20251125001Phase 1Completed

Sponsor
Phrae Hospital
Start
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1 trial of bupivacaine in hip fracture, sponsored by Phrae Hospital. Primary endpoints: intraoperative hypotension and postoperative pain. Started Sep 2025; status: completed.

02

Drugs

bupivacaine
03

Conditions

hip fracture

Beyond the preview

Go deeper on TCTR20251125001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20251125001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call